首页 国际期刊 生物期刊 期刊详情(非官网)
400-808-1701

Cell Death Discovery

Cell Death Discovery杂志,由Springer Nature出版,于2015年创刊,1 issue/year,出版语言English,ISSN:2058-7716,E-ISSN:2058-7716。

投稿咨询
Cell Death Discovery
Cell Death Discovery
Cell Death Discovery
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
10.4
CiteScore
13.2
期刊收录
SCI、SCIE

Cell Death Discovery(中文译名:《细胞死亡发现》),ISSN:2058-7716,EISSN:2058-7716,是Springer Nature出版的国际性学术期刊,创刊于2015年,以1 issue/year形式稳定发行,2026年总发文量约597篇。该刊采用OA开放访问,学科归属为Biochemistry, Genetics and Molecular Biology - Cell Biology。该刊是生物、细胞生物学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达10.4,2025年期刊CiteScore为13.2,2025年期刊自引率约1%,在中科院期刊分区体系中位列生物学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Cell Death Discovery长期聚焦生物、细胞生物学及相关产业的技术应用前沿,平均审稿周期9 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对生物、细胞生物学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Russia、Italy、GERMANY (FED REP GER)、England、Japan等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
生物学
1区
CELL BIOLOGY 细胞生物学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
生物学
2区
CELL BIOLOGY 细胞生物学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
生物学
2区
CELL BIOLOGY 细胞生物学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CELL BIOLOGY SCIE Q1 30 / 207

85.7

学科:CELL BIOLOGY SCIE Q1 51 / 207

75.6

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CELL BIOLOGY SCIE Q1 48 / 205

76.8

学科:CELL BIOLOGY SCIE Q2 64 / 205

69.02


中国学者近期发文

1
Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis (vol 12, 186, 2026

Author:Li, Ling; Zhang, Xiujuan; Lin, Yanni; Ren, Xinxin; Xie, Tian; Lin, Jing; Wu, Shumeng; Ye, Qinong

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03069-z

2
CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells (vol 12, 5, 2026

Author:Chen, Chuyun; Zhang, Fubin; Shen, Jiayi; Zheng, Qi; Zhang, Zhiyun; Lu, Shun; Liu, Lixiao; Zhu, Tianhong; Du, Yongming; Guan, Yutao

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03008-y

3
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways (vol 10, 86 , 2024

Author:Gan, Kai; Lian, Haoyu; Yang, Tao; Huang, Jian; Chen, Junchun; Su, Yuangang; Zhao, Jinmin; Xu, Jiake; Liu, Qian

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03007-z

4
Glycolytic reprogramming mediated by the ADAM12/IGF1 axis promotes ossification of the posterior longitudinal ligamen

Author:Zhao, Qi; Wu, Hao; Xie, Dong; Shi, Mingliang; Niu, Baocheng; Yang, Lili

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03044-8

5
SMARCA4 promotes lineage plasticity and enzalutamide resistance in prostate cancer by regulating PROX1 via H3K27 acetylatio

Author:Wu, Chenwei; Luo, Mayao; Wu, Chaojian; Yuan, Yi; Li, Yadong; Liao, Yuanpeng; Zhang, Yifan; Huang, Xin; Wang, Mengqi; Lv, Shidong; Wei, Qiang

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03068-0

6
RUNX1 restrains STAT1-GITRL signaling to shape an immunosuppressive CRC microenvironmen

Author:He, Wenting; Zheng, Lisheng; Huang, Weiye; Li, Keren; Chen, Yitian; Zeng, Rui; Lin, Zhihao; Xu, Yangwei; Hu, Shengfeng; Zhang, Qingling

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03053-7

7
ATP6V1B2 alleviates hepatic steatosis by promoting lysosomal acidification in hepatocyte

Author:Xu, Ruizi; Yang, Fuji; Zhang, Zhuan; Cheng, Fang; Li, Shihui; Yan, Yongmin; Wang, Yanan; Zhou, Jing

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03052-8

8
tRF-3005a regulates exon skipping of SPAG4 by interacting with RALY to drive gastric cancer progressio

Author:Cui, Huaiping; Yuan, Yancong; Yin, Yizhe; Gao, Ruihong; Liu, Zhaodong; Peng, Lipan; Wang, Jinshen; Wang, Zhu; Song, Tingting; Liu, Jinglei

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03049-3

9
p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potential

Author:Cong, Yujia; He, Zhenglin; Hao, Hanming; Chen, Haoran; Chen, Anqi; Li, Chunyi; Hu, Yue; Cong, Xianling

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03060-8

10
Dynamic changes of the immune microenvironment in ovarian cancer following neoadjuvant chemotherap

Author:Wu, Mingjie; Lv, Fei; Jin, Yi; Wang, Shuai; Meng, Lijun; Tong, Jinyi; Zou, Ruoyao

Journal: CELL DEATH DISCOVERY. 2026; Vol. 12, Issue 1, pp. -. DOI: 10.1038/s41420-026-03070-6


在线咨询

Cell Death Discovery

国际简称:CELL DEATH DISCOV参考译名:细胞死亡发现

年发文量:597 CiteScore:13.2 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:77.89%

杂志社联系方式:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Cell Death Discovery